Clostridium difficile Infections amongst Patients with Haematological Malignancies: A Data Linkage Study
Open Access
- 17 June 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (6), e0157839
- https://doi.org/10.1371/journal.pone.0157839
Abstract
Identify risk factors for Clostridium difficile infection (CDI) and assess CDI outcomes among Australian patients with a haematological malignancy. A retrospective cohort study involving all patients admitted to hospitals in Western Australia with a haematological malignancy from July 2011 to June 2012. Hospital admission data were linked with all hospital investigated CDI case data. Potential risk factors were assessed by logistic regression. The risk of death within 60 and 90 days of CDI was assessed by Cox Proportional Hazards regression. There were 2085 patients of whom 65 had at least one CDI. Twenty percent of CDI cases were either community-acquired, indeterminate source or had only single-day admissions in the 28 days prior to CDI. Using logistic regression, having acute lymphocytic leukaemia, neutropenia and having had bacterial pneumonia or another bacterial infection were associated with CDI. CDI was associated with an increased risk of death within 60 and 90 days post CDI, but only two deaths had CDI recorded as an antecedent factor. Ribotyping information was available for 33 of the 65 CDIs. There were 19 different ribotypes identified. Neutropenia was strongly associated with CDI. While having CDI is a risk factor for death, in many cases it may not be a direct contributor to death but may reflect patients having higher morbidity. A wide variety of C. difficile ribotypes were found and community-acquired infection may be under-estimated in these patients.Keywords
Funding Information
- Sanofi Pasteur
This publication has 32 references indexed in Scilit:
- Long-Term Health Risks for Children and Young Adults after Infective GastroenteritisEmerging Infectious Diseases, 2010
- Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spreadThe Lancet Infectious Diseases, 2010
- A decade of data linkage in Western Australia: strategic design, applications and benefits of the WA data linkage systemAustralian Health Review, 2008
- Recommendations for Surveillance of Clostridium difficile–Associated DiseaseInfection Control & Hospital Epidemiology, 2007
- Risk factors for Clostridium difficile-associated diarrhea on an adult hematology-oncology wardEuropean Journal of Clinical Microbiology & Infectious Diseases, 2006
- Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myelomaBone Marrow Transplantation, 2006
- A randomized trial of high-versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabinePublished by American Society of Hematology ,2005
- Clostridium difficileInfection in Patients with NeutropeniaClinical Infectious Diseases, 2001
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- Clostridium difficile in haematological malignancy.Journal of Clinical Pathology, 1985